Microsoft PowerPoint - 3. Wiltrout NFAC 02_04_14_final.pptx - Cancer immunotherapy - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-02-26 10:31:14 Vaccination Immunotherapy Melanoma Cytokines Interleukin 21 Medicine Cancer treatments Cancer vaccine		Microsoft PowerPoint - 3. Wiltrout NFAC 02_04_14_final.pptx Add to Reading List Source URL: deainfo.nci.nih.gov Download Document from Source Website File Size: 901,59 KB Share Document on Facebook

	Data Sheet: CellGro® Recombinant Human Interleukin-21 (rh IL-21) Preclinical Grade - Order No.: 050  DocID: 1uVMw - View Document
	Microsoft PowerPoint - AM0010-001 TIP Mayfinal DocID: 1pufE - View Document
	PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2, DocID: 1p7VM - View Document
	ASCO Annual Meeting - Chicago, IL, May 29 –June 2, 2015; Abstract #3017 Poster #: 343 A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors. Jeffrey R. Infante1, DocID: 1ozwo - View Document
	CD8+ cell depletion alters cytokine gene expression in the peripheral nervous systems of herpes simplex virus infected mice David C. Tscharke1,2,Anthony Simmons1 1.Infectious Diseases Laboratories, Institute of Medical a DocID: 1fJLf - View Document